Germline <i>BRCA</i> Mutations Are Associated With Higher Risk of Nodal Involvement, Distant Metastasis, and Poor Survival Outcomes in Prostate Cancer
Elena Castro(Research Institute Hospital 12 de Octubre), Rosalind A. Eeles(Royal Marsden NHS Foundation Trust), Tokhir Dadaev(Institute of Cancer Research), Antonis C. Antoniou(Weatherford College), Louise Izatt(Guy's and St Thomas' NHS Foundation Trust), Nadiya Mahmud(Imperial College London), Chee Goh(Institute of Cancer Research), Douglas F. Easton(University of Cambridge), Lucy Side(Unknown), Zsofia Kote‐Jarai(Institute of Cancer Research), Marc Tischkowitz(University of Cambridge), Koveela Govindasami(Institute of Cancer Research), Audrey Ardern‐Jones(Royal Marsden NHS Foundation Trust), Rosemary Wilkinson(Institute of Cancer Research), Edward J. Saunders(Institute of Cancer Research), Jacqueline Eason(Nottingham University Hospitals NHS Trust), David Olmos(Spanish National Cancer Research Centre), Michael J. Kennedy(University of Virginia), Alex Murray(University Medical Center Utrecht), Huw Dorkins(London North West Healthcare NHS Trust), D. Gareth Evans(Manchester Academic Health Science Centre), Malgorzata Tymrakiewicz(Institute of Cancer Research), Trevor Cole(Birmingham Women's Hospital), Alan Donaldson(University Hospitals Bristol NHS Foundation Trust), Mary Porteous(University of Edinburgh), Fiona Douglas(University of Southern California), Michelle Guy(Institute of Cancer Research), Rosemarie Davidson(The Netherlands Cancer Institute), Carole Brewer(Royal Devon and Exeter Hospital), Susan Peock(Cancer Research UK), Emma Sawyer(Centro Nacional de Investigaciones Científicas), Shirley Hodgson(St Thomas' Hospital), Debra Frost(University of Cambridge), Daniel Leongamornlert(University of Southern California), Diana Eccles(Princess Anne Hospital), Jackie Cook(Sheffield Children's Hospital)
Cited by 833
Related Papers
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
|The American Journal of Human Genetics|2003|3.7k
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
|New England Journal of Medicine|2015|2.2k
The evolutionary history of lethal metastatic prostate cancer
|Nature|2015|1.4k